Stimulant use and stimulant use disorders in Australia: findings from the National Survey of Mental Health and Wellbeing

Grant E Sara, Philip M Burgess, Meredith G Harris, Gin S Malhi and Harvey A Whiteford
Med J Aust 2011; 195 (10): 607-609. || doi: 10.5694/mja11.10360
  • Grant E Sara1,2
  • Philip M Burgess2
  • Meredith G Harris2
  • Gin S Malhi1
  • Harvey A Whiteford2

  • 1 Sydney Medical School, University of Sydney, Sydney, NSW.
  • 2 School of Population Health, Queensland Centre for Mental Health Research, University of Queensland, Brisbane, QLD.

Competing interests:

No relevant disclosures.

  • 1. Degenhardt L, Roxburgh A, Black E, et al. The epidemiology of methamphetamine use and harm in Australia. Drug Alcohol Rev 2008; 27: 243-252.
  • 2. Ministerial Council on Drug Strategy. National Amphetamine-Type Stimulant Strategy 2008–2011. Canberra: Australian Government, 2008.
  • 3. Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of amphetamine use. Drug Alcohol Rev 2008; 27: 253-262.
  • 4. Australian Institute of Health and Welfare. 2007 Drug Strategy Household Survey: detailed findings. Canberra: AIHW, 2008. (AIHW Cat. No. PHE 107; Drug Statistics Series No. 22.)
  • 5. Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health. The NSDUH report: methamphetamine use. Rockville, Md: Office of Applied Studies, 2007.
  • 6. Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: Vol. I. Summary of national findings. Rockville, Md: Office of Applied Studies, 2010.
  • 7. Adlaf E, Begin P, Sawka E, editors. Canadian Addiction Survey (CAS): a national survey of Canadians’ use of alcohol and other drugs: prevalence of use and related harms: detailed report. Ottowa: Canadian Centre on Substance Abuse, 2005.
  • 8. Coulthardt M, Farrell M, Singleton N, Meltzer H. Tobacco, alcohol and drug use and mental health. London: TSO, 2002.
  • 9. Wilkins C, Sweetsur P. Trends in population drug use in New Zealand: findings from national household surveying of drug use in 1998, 2001, 2003, and 2006. N Z Med J 2008; 121: 61-71.
  • 10. McKetin R, McLaren J, Kelly E, et al. Estimating the number of regular and dependent methamphetamine users in Australia. Technical Report No. 230. Sydney: National Drug and Alcohol Research Centre, 2005.
  • 11. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA 1990; 264: 2511-2518.
  • 12. Teesson M, Baillie A, Lynskey M, et al. Substance use, dependence and treatment seeking in the United States and Australia: a cross-national comparison. Drug Alcohol Depend 2006; 81: 149-55.
  • 13. Kessler RC, Aguilar-Gaxiola S, Berglund PA, et al. Patterns and predictors of treatment seeking after onset of a substance use disorder. Arch Gen Psychiatry 2001; 58: 1065-1071.
  • 14. Degenhardt L, Chiu WT, Sampson N, et al. Epidemiological patterns of extra-medical drug use in the United States: evidence from the National Comorbidity Survey Replication, 2001–2003. Drug Alcohol Depend 2007; 90: 210-223.
  • 15. Vega WA, Aguilar-Gaxiola S, Andrade L, et al. Prevalence and age of onset for drug use in seven international sites: results from the international consortium of psychiatric epidemiology. Drug Alcohol Depend 2002; 68: 285-297.
  • 16. Gureje O, Lasebikan VO, Kola L, Makanjuola VA. Lifetime and 12-month prevalence of mental disorders in the Nigerian Survey of Mental Health and Well-Being. Br J Psychiatry 2006; 188: 465-471.
  • 17. Jacobi F, Wittchen HU, Holting C, et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med 2004; 34: 597-611.
  • 18. Lee S, Tsang A, Zhang MY, et al. Lifetime prevalence and inter-cohort variation in DSM-IV disorders in metropolitan China. Psychol Med 2007; 37: 61-71.
  • 19. Stein DJ, Seedat S, Herman A, Moomal H, Heeringa SG, Kessler RC, et al. Lifetime prevalence of psychiatric disorders in South Africa. Br J Psychiatry 2008; 192: 112-117.
  • 20. Wells JE, Baxter J, Schaaf D, editors. Substance use disorders in Te Rau Hinengaro: the New Zealand Mental Health Survey. Wellington: Alcohol Advisory Council of New Zealand, 2006.
  • 21. Australian Bureau of Statistics. National Survey of Mental Health and Wellbeing: summary of results, 2007. Canberra: ABS, 2008. (ABS Cat. No. 4326.0.)
  • 22. Slade T, Johnston A, Oakley Browne MA, et al. 2007 National Survey of Mental Health and Wellbeing: methods and key findings. Aust N Z J Psychiatry 2009; 43: 594-605.
  • 23. World Health Organization. Composite international diagnostic interview. Geneva: WHO, 1997.
  • 24. World Health Organization. International classification of diseases and related health problems, 10th revision (ICD-10). 2nd ed. Geneva: WHO, 1992.
  • 25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Text revision. Washington, DC: APA, 2000.
  • 26. Australian Bureau of Statistics. Technical manual: National Survey of Mental Health and Wellbeing, Confidentialised Unit Record Files 2007. Canberra: ABS, 2009. (ABS Cat. No. 43290.)
  • 27. Degenhardt L, Coffey C, Carlin JB, et al. Who are the new amphetamine users? A 10-year prospective study of young Australians. Addiction 2007; 102: 1269-1279.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.